Fig. 2From: Microenvironmental effects limit efficacy of thymoquinone treatment in a mouse model of ovarian cancerEffects of short- and long-term TQ treatment in ID8-NGL tumors. a Representative vehicle or TQ-treated mice after 30 days treatment. b Volume of ascites, number of peritoneal implants and mesenteric tumor mass in vehicle or TQ-treated mice after 30 days. c Protein levels of the apoptotic marker, cleaved PARP (CL PARP) and proliferation marker, PCNA, and d luciferase activity of the NGL reporter, in tumors harvested from mice treated with thrice weekly 20 mg/kg TQ or vehicle (Veh) for 10 or 30 days. *p < 0.01 compared to vehicle; Mann–Whitney testBack to article page